Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Operating Expenses | 0 | 3,001 | 2,777 | 1,691 | -71,500 |
| Operating Income | N/A | -3,001 | -2,777 | -1,691 | -7,428 |
| Other Income | 0 | -1,346 | 251 | -242 | 1,969 |
| Pre-tax Income | 0 | -4,347 | -2,526 | -1,933 | -5,459 |
| Income Tax | N/A | N/A | N/A | 1 | -1 |
| Net Income Continuous | N/A | -4,347 | -2,526 | -1,934 | -5,458 |
| Net Income Discontinuous | N/A | 43,748 | -6,864 | -3,221 | -427 |
| Net Income | $N/A | $39,401 | $-9,390 | $-5,155 | $-5,885 |
| EPS Basic Total Ops | N/A | 4.82 | -1.15 | -0.63 | -0.72 |
| EPS Basic Continuous Ops | N/A | -0.53 | -0.31 | -0.24 | -0.67 |
| EPS Basic Discontinuous Ops | N/A | 5.35 | -0.84 | -0.39 | -0.05 |
| EPS Diluted Total Ops | N/A | 4.82 | -1.15 | -0.63 | -0.72 |
| EPS Diluted Continuous Ops | N/A | -0.53 | -0.31 | -0.24 | -0.67 |
| EPS Diluted Discontinuous Ops | N/A | 5.35 | -0.84 | -0.39 | -0.05 |
| EBITDA(a) | $N/A | $-2,997 | $-2,772 | $-1,687 | $71,704 |